Oxygenta Pharmaceutical Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Profit before tax

-11.37

-0.49

3.14

-9.93

-3.49

Net cashflow-operating activity

-1.63

-1.68

-1.62

-6.58

-7.79

Net cash used in investing activity

-9.64

-4.94

-6.72

-0.50

-0.56

Netcash used in fin. activity

11.22

6.33

8.67

3.19

8.36

Net inc/dec in cash and equivlnt

-0.05

-0.29

0.33

-3.89

0.01

Cash and equivalnt begin of year

0.16

0.45

0.12

0.02

0.01

Cash and equivalnt end of year

0.11

0.16

0.45

-3.87

0.02